Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Heart Failure
Search: search_blue_button Advanced Search
Published Online
on May 8, 2009

Circulation: Heart Failure. 2009
Published online before print May 8, 2009, doi: 10.1161/CIRCHEARTFAILURE.108.844845
A more recent version of this article appeared on July 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2/4/351    most recent
CIRCHEARTFAILURE.108.844845v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spinale, F. G.
Right arrow Articles by Stroud, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spinale, F. G.
Right arrow Articles by Stroud, R. E.
Related Collections
Right arrow Structure
Right arrow Heart failure - basic studies

Original Article

Cardiac Restricted Over-Expression of Membrane Type-1 Matrix Metalloproteinase in Mice: Effects on Myocardial Remodeling with Aging

Francis G. Spinale1; G. Patricia Escobar; Rupak Mukherjee; Juozas A. Zavadzkas; Stuart M. Saunders; Laura B. Jeffords; Allyson M. Leone; Christy Beck; Shenikqua Bouges and Robert E. Stroud

Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, SC

1 E-mail: wilburnm{at}musc.edu

Background—The direct consequences of a persistently increased myocardial expression of the unique matrix metalloproteinase (MMP), membrane type-1 (MT1-MMP) on myocardial remodeling remained unexplored.

Methods and Results—Cardiac restricted MT1-MMPexp was constructed in mice using the full length human MT1-MMP gene ligated to the myosin heavy chain promoter, which yielded approximately a 200% increase in MT1-MMP when compared to age/strain matched wild type mice (WT). LV function and geometry was assessed by echocardiography in 3 month ("young") WT (n=32) and MT1-MMPexp (n=20) mice, and compared to 14 month ("middle age") WT (n=58) and MT1-MMPexp (n=35) mice. LV end-diastolic volume was similar between the WT and MT1-MMPexp young groups as was LV ejection fraction. In the middle age WT mice, LV end-diastolic volume and ejection fraction was similar to young WT mice. However, in the MT1-MMPexp middle age mice, LV end-diastolic volume was approximately 43% higher and LV ejection fraction 40% lower (both p<0.05). Moreover, in the middle age MT1-MMPexp mice, myocardial fibrillar collagen increased by nearly 2-fold and was associated with an approximate 3-fold increase in the processing of the pro-fibrotic molecule, latency-associated transforming growth factor binding protein. In a second study, 14 day survival following myocardial infarction was significantly lower in middle aged MT1-MMPexp mice.

Conclusions—Persistently increased myocardial MT1-MMP expression, in and of itself, caused LV remodeling, myocardial fibrosis, dysfunction and reduced survival following myocardial injury. These findings suggest that MT1-MMP plays a mechanistic role in adverse remodeling within the myocardium.

Key Words: Aging • Matrix • Myocardial remodeling • Ventricular function